Free tool
FAERS Monitor: Dulera
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022518 or its brand name (Dulera, Formoterol Fumarate, Mometasone Furoate). Reports on generic versions are filed under their own applications.
Reports
16,226
Serious
4,892
30% of reports
Hospitalization
2,500
Death reported
443
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- product quality issue3,321
- no adverse event3,122
- drug dose omission2,135
- dyspnoea1,794
- poor quality device used1,556
- device malfunction1,238
- cough913
- drug ineffective886
- asthma858
- product dose omission issue769
- fatigue658
- headache627
- incorrect dose administered609
- product use issue562
- pneumonia510
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2010 | 1 |
| 2011 | 12 |
| 2012 | 512 |
| 2013 | 1,067 |
| 2014 | 1,447 |
| 2015 | 1,603 |
| 2016 | 1,892 |
| 2017 | 1,606 |
| 2018 | 1,400 |
| 2019 | 1,294 |
| 2020 | 1,209 |
| 2021 | 951 |
| 2022 | 828 |
| 2023 | 446 |
| 2024 | 510 |
| 2025 | 486 |
| 2026 | 962 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,933 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| poor quality device usedSignal | 1,556 | 237.7 | 225.7 | 309,893 |
| product quality issueSignal | 3,321 | 32.5 | 31.5 | 99,411 |
| device malfunctionSignal | 1,238 | 23.2 | 22.0 | 25,934 |
| no adverse eventSignal | 3,122 | 22.7 | 22.0 | 64,209 |
| drug dose omissionSignal | 2,135 | 16.9 | 16.3 | 31,859 |
| asthmaSignal | 858 | 9.9 | 9.3 | 6,848 |
| coughSignal | 913 | 4.2 | 4.0 | 2,272 |
| dyspnoeaSignal | 1,794 | 4.1 | 3.9 | 4,335 |
| product use issueSignal | 562 | 3.9 | 3.6 | 1,208 |
| incorrect dose administeredSignal | 609 | 3.5 | 3.2 | 1,074 |
| product dose omission issueSignal | 769 | 3.4 | 3.2 | 1,313 |
| pneumoniaSignal | 510 | 2.0 | 1.9 | 275 |
| headache | 627 | 1.3 | 1.2 | 44 |
| fatigue | 658 | 1.1 | 1.0 | 6 |
| drug ineffective | 886 | 0.9 | 0.8 | 18 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.